Skip to main content
Evergreen Ledger
← Back to bills

SGA 9184

In Committee

Senate

HAWKINS B. DEFRANCE

  1. Introduced (completed)
  2. 2
    Committee (current stage)
  3. 3
    Floor Vote (not started)
  4. 4
    Opposite Chamber (not started)
  5. 5
    Governor (not started)
  6. 6
    Signed (not started)

This status may be delayed. See Action History below for the latest updates.

How does a bill become law?
  1. Introduced: The bill is filed and assigned a number.
  2. Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
  3. Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
  4. Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
  5. Governor: The Governor reviews the bill and decides whether to sign or veto it.
  6. Signed: The bill has been signed into law.
Introduced: January 14, 2025
Last Action: April 14, 2025
Status: S Confirmed
View Bill Text (HTML) (opens in new tab)View Bill Text (PDF) (opens in new tab)

AI Analysis

This analysis was generated by AI and may contain errors. It is not legal advice. Always refer to the official bill text for authoritative information.
People & CommunitiesBalancedCorporate & Wealthy Interests

This bill formally appoints Hawkins B. DeFrance to the Pharmacy Quality Assurance Commission, effective December 4, 2024, for a fixed term ending January 19, 2028.

  • Appoints Hawkins B. DeFrance as a member of the Pharmacy Quality Assurance Commission.
  • Sets the term of service to end on January 19, 2028.

Who is affected

  • Hawkins B. DeFrance — The individual named, Hawkins B. DeFrance, is appointed to serve as a member of the Pharmacy Quality Assurance Commission.
Effective: December 4, 2024
Model: Intel/Qwen3-Coder-Next-int4-AutoRoundGenerated: Mar 19, 2026, 10:04 PM

Pro/Con Analysis

Stronger case for benefits

Potential Benefits (1)

  • This bill ensures continuity and stability in pharmacy regulation by formally appointing a qualified individual to a state oversight body responsible for licensing, discipline, and quality assurance for pharmacists and pharmacies — a function critical to public health and consumer protection.

    Local GovernmentRef: Appoints Hawkins B. DeFrance as a Member of the Pharmacy Quality Assurance Commission

Who Is Most Affected

  • Hawkins B. DeFrancePositive Impact

    Hawkins B. DeFrance gains formal authority and responsibility to participate in regulatory decisions affecting pharmacy practice, including licensing, enforcement, and policy development — a position of professional influence and public trust.

  • Pharmacy Quality Assurance CommissionMixed Impact

    The Pharmacy Quality Assurance Commission benefits from having a full complement of members, improving its capacity to carry out its statutory duties, including oversight of drug distribution, prescription accuracy, and patient safety.

  • General Public / PatientsPositive Impact

    Washingtonians benefit indirectly from consistent, high-quality pharmacy oversight — including reduced medication errors, enforcement of standards, and accountability for drug dispensing practices.

  • Pharmacists & Pharmacy OperatorsMixed Impact

    Pharmacists and pharmacy operators remain subject to the same regulatory framework; this appointment does not alter rules or enforcement priorities, but ensures the commission has quorum to act.

  • State Government / AgenciesMixed Impact

    State government operations continue as usual; no fiscal or structural change is triggered by this appointment, as the position is already authorized and funded.